MED
What one share of Medifast holds
Miscellaneous Food Preparations and Kindred Products
Medifast, Inc. (“Medifast,” the “Company,” “we” or “us”) is the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system. As we enter 2026, the Company is moving from transformation to execution, leveraging its extensive experience in structured weight loss coupled with recent scientific research and enhanced product offerings to address the needs of a broader metabolic health market.
Medifast’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $28.83 |
|---|---|
| Profit | −$2.33 |
| Capex (buildings and equipment) | $0.43 |
| Free cash flow | $0.36 |
| Dividends | $0.02 |
| Cash and investments | $6.43 |
| Book value | $17.56 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $11.52 | $0.77 | $0.35 | $0.95 | — | $3.54 |
| 2010 | $17.67 | $1.35 | $0.83 | $1.15 | — | $4.66 |
| 2011 | $21.00 | $1.31 | $1.01 | $1.45 | — | $5.40 |
| 2012 | $23.19 | $1.16 | $0.59 | $2.34 | — | $6.59 |
| 2013 | $23.45 | $1.73 | $0.82 | $2.24 | $0.00 | $7.50 |
| 2014 | $22.33 | $1.03 | $0.55 | $1.45 | $0.00 | $6.66 |
| 2015 | $22.60 | $1.66 | $0.23 | $2.20 | $0.25 | $7.51 |
| 2016 | $22.98 | $1.49 | $0.24 | $1.88 | $1.07 | $8.09 |
| 2017 | $24.95 | $2.29 | $0.27 | $3.31 | $1.44 | $8.90 |
| 2018 | $41.48 | $4.62 | $0.41 | $4.63 | $2.19 | $9.19 |
| 2019 | $58.90 | $6.43 | $0.83 | $6.12 | $3.38 | $8.91 |
| 2020 | $78.89 | $8.68 | $0.50 | $11.76 | $4.52 | $13.36 |
| 2021 | $129.19 | $13.89 | $2.90 | $5.11 | $5.68 | $17.47 |
| 2022 | $141.77 | $12.73 | $1.48 | $15.78 | $6.56 | $14.26 |
| 2023 | $98.16 | $9.10 | $0.59 | $12.93 | $4.95 | $18.49 |
| 2024 | $54.95 | $0.19 | $0.68 | $1.55 | $0.00 | $19.21 |
| 2025 | $35.13 | −$1.70 | $0.51 | $0.11 | $0.00 | $18.10 |